1. Antidepressants and withdrawal phenomena

   Newsletter Article 07 February 2013 Pages: 2 - 2

2. Adverse reactions to tocainide and mexiletine

   Newsletter Article 07 February 2013 Pages: 2 - 2

3. Aminoglycosides and hypomagnesaemic tetany

   Newsletter Article 07 February 2013 Pages: 2 - 2

4. Adverse effects of sulfhydryl compounds

   Newsletter Article 07 February 2013 Pages: 2 - 3

5. The side effects of etodolac

   Newsletter Article 07 February 2013 Pages: 3 - 3

6. α-Interferon and drug-induced immune thrombocytopenia

   Newsletter Article 07 February 2013 Pages: 4 - 4

7. Fenfluramine and irreversible pulmonary hypertension

   Newsletter Article 07 February 2013 Pages: 4 - 4

8. Minimal toxicity associated with guanabenz overdose

   Newsletter Article 07 February 2013 Pages: 4 - 4

9. Treatment of propranolol overdose with glucagon

   Newsletter Article 07 February 2013 Pages: 4 - 5

10. Acenocoumarol⋆

    Newsletter Article 07 February 2013 Pages: 5 - 5

11. Aciclovir⋆

    Newsletter Article 07 February 2013 Pages: 5 - 5

12. Ampicillin⋆

    Newsletter Article 07 February 2013 Pages: 5 - 5

13. Amyl nitrite⋆

    Newsletter Article 07 February 2013 Pages: 5 - 5

14. Anti-inflammatories, non-steroidal

    Newsletter Article 07 February 2013 Pages: 5 - 5

15. The side effects of buspirone

    Newsletter Article 07 February 2013 Pages: 6 - 6

16. Aspirin⋆

    Newsletter Article 07 February 2013 Pages: 7 - 7

17. Carbamazepine interaction

    Newsletter Article 07 February 2013 Pages: 7 - 7

18. Clonidine⋆

    Newsletter Article 07 February 2013 Pages: 7 - 7

19. Cotrimoxazole interaction see Pimozide interaction

    Newsletter Article 07 February 2013 Pages: 7 - 7

20. Dextropropoxyphene interaction see Carbamazepine interaction

    Newsletter Article 07 February 2013 Pages: 8 - 8

21. Diclofenac⋆

    Newsletter Article 07 February 2013 Pages: 8 - 8

22. Doxycycline

    Newsletter Article 07 February 2013 Pages: 8 - 8

23. Erythromycin interaction see Carbamazepine interaction

    Newsletter Article 07 February 2013 Pages: 8 - 8

24. Fenfluramine⋆

    Newsletter Article 07 February 2013 Pages: 8 - 8

25. Fentanyl⋆

    Newsletter Article 07 February 2013 Pages: 8 - 8

26. Lidocaine

    Newsletter Article 07 February 2013 Pages: 8 - 8

27. Methyldopa

    Newsletter Article 07 February 2013 Pages: 8 - 8

28. Mianserin

    Newsletter Article 07 February 2013 Pages: 8 - 9

29. Nifedipine

    Newsletter Article 07 February 2013 Pages: 9 - 9

30. Pethidine

    Newsletter Article 07 February 2013 Pages: 9 - 9

31. Phenelzine

    Newsletter Article 07 February 2013 Pages: 9 - 9

32. Pimozide interaction⋆

    Newsletter Article 07 February 2013 Pages: 9 - 9

33. Propafenone

    Newsletter Article 07 February 2013 Pages: 9 - 9

34. Propranolol

    Newsletter Article 07 February 2013 Pages: 9 - 9

35. Pyrimethamine + sulfadoxine + chloroquine

    Newsletter Article 07 February 2013 Pages: 10 - 10

36. Spironolactone

    Newsletter Article 07 February 2013 Pages: 10 - 10

37. Sulfasalazine

    Newsletter Article 07 February 2013 Pages: 10 - 10

38. Tiaprofenic acid

    Newsletter Article 07 February 2013 Pages: 10 - 10

39. Tocopherol

    Newsletter Article 07 February 2013 Pages: 10 - 10

40. Trimipramine⋆

    Newsletter Article 07 February 2013 Pages: 10 - 10

41. Vancomycin

    Newsletter Article 07 February 2013 Pages: 10 - 11

42. Verapamil

    Newsletter Article 07 February 2013 Pages: 11 - 11

43. Adverse effects of tocainide

    Newsletter Article 07 February 2013 Pages: 11 - 12